Evidence map›Paper›PMID 23700444›Full record

ArticlePloS one2013

Crystal structures of carbamate kinase from Giardia lamblia bound with citric acid and AMP-PNP.

Kap Lim, Liudmila Kulakova, Andrey Galkin, Osnat Herzberg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kap LimInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Liudmila Kulakova
Andrey Galkin
Osnat Herzberg
Advanced Bioscience Laboratories (United States) · USInstitute for Bioscience and Biotechnology Research

Funding

Giardia drug targets: Structure, function and inhibitorsR56AI059733 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI HERZBERG, OSNAT · 2010 to 2010
$714k
NIAID NIH HHS R56 AI059733NIAID NIH HHS R56AI059733
6 · The paper itself

Abstract

The parasite Giardia lamblia utilizes the L-arginine dihydrolase pathway to generate ATP from L-arginine. Carbamate kinase (CK) catalyzes the last step in this pathway, converting ADP and carbamoyl phosphate to ATP and ammonium carbamate. Because the L-arginine pathway is essential for G. lamblia survival and absent in high eukaryotes including humans, the enzyme is a potential target for drug development. We have determined two crystal structures of G. lamblia CK (glCK) with bound ligands. One structure, in complex with a nonhydrolyzable ATP analog, adenosine 5'-adenylyl-β,γ-imidodiphosphate (AMP-PNP), was determined at 2.6 Å resolution. The second structure, in complex with citric acid bound in the postulated carbamoyl phosphate binding site, was determined in two slightly different states at 2.1 and 2.4 Å resolution. These structures reveal conformational flexibility of an auxiliary domain (amino acid residues 123-170), which exhibits open or closed conformations or structural disorder, depending on the bound ligand. The structures also reveal a smaller conformational change in a region associated the AMP-PNP adenine binding site. The protein residues involved in binding, together with a model of the transition state, suggest that catalysis follows an in-line, predominantly dissociative, phosphotransfer reaction mechanism, and that closure of the flexible auxiliary domain is required to protect the transition state from bulk solvent.

Indexed as

Adenylyl ImidodiphosphateAmino Acid SequenceCatalytic DomainCitric AcidCrystallography, X-RayGiardia lambliaHydrogen BondingModels, ChemicalMolecular Sequence DataPhosphotransferases (Carboxyl Group Acceptor)Protein BindingProtein Structure, SecondaryProtozoan ProteinsAdenylyl Imidodiphosphatecarbamate kinaseCitric AcidPhosphotransferases (Carboxyl Group Acceptor)Protozoan Proteins

Identifiers

PMID23700444
PMCPMC3659122
OpenAlexW2079701252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.